KRAS and arteriovenous hemangioma/malformation: Within 4 of 11 (36%) individuals with fast-flow lesions (arteriovenous malformations [AVM]) we identified somatic variants in KRAS and MAP2K1 with VAFs ranging from 1.27% to 9.98% (Table 1).